In the middle of the Pandemic- My learnings during the COVID-19 experience

Wow! I could have never imagined this would have been such a great opportunity to re-evaluate your daily life! Getting into this restriction thing with working from home and #stayathome measures, I felt awkward at first. Being a person that pursues freedom of choice this was really challenging at first . But as the time…

European Society of Cardiology takes its education full virtual

The ESC has announced that although EHRA Congress was cancelled due to COVID-19, effort is being made to keep scientific exchange going. Here is their announcement: NEW: #EHRAessentials4U is your hub for the latest scientific developments in arrhythmia. Bookmark & share this page https://bit.ly/3aWgYbX Regular updates. Free for everyone until 9 July. EHRA_ESC

Disease awareness campaigns: to inform or not to inform? And if so, how?

Anyone who has ever worked as a marketer in the pharma industry and created a product launch plan has surely included a disease awareness campaign. Some of them were lost in the excecution, others in  strict regulations  and others were  really a blast! Looking for best practices in Disease awareness campaings?  By digging a little…

Physicians in social media:What are their drivers?

Medical associations dynamically embraced social media the last few years and a rising number of physicians are engaging with each other in that environment. Decision to go towards this direction was probably based on research and review like the one presented here In general physicians seek information and scientific exchange. Expertise though seems to  be…

How do physicians embrace social media?

Ever thought of building a campaign for physicians in social media? Ever wondered how they  see themselves in this digital environment? Here’s what I found interesting while looking around myself:   Articles generated by digital marketers like the one from Sofware Advice which I found really analytic and thoroughly goes through all of the drivers…

The FDA is Cracking Down on Big Pharma Social Media

The FDA sent one company a warning letter for Facebook “likes”

 

The FDA often sends warning letters to companies for violating FDA regulation on how their products are marketed. For instance, if a company is advertising its product as a treatment for an ailment its not approved for, they’re going to hear from the FDA. 

 

So is the case with a recent FDA warning letter to Zarbee’s Naturals, which the FDA scolded for not only claiming to treat conditions like coughs (supplements cannot make these claims, otherwise they would drugs and regulated as such), but for the company’s Facebook “likes” and tweets.

 

Of course, some pharmaceutical companies find the FDA guidance overbearing. “If the FDA is going to require the same type of fine print that you see in a magazine ad to be in a tweet, then the FDA is essentially taking that tool away from patients who may want to hear from companies as well as healthcare professionals,” Jeffrey K. Francer, vice president and senior counsel with Pharmaceutical Research and Manufacturers of America told the publication GEN in an interview. “I assume that the FDA believes that its own tweets are truthful and not misleading. If they believe that, then why couldn’t a company use Twitter in the same way that the FDA is using Twitter?” Francer thinks the guidelines interfere with the First Amendment.

Source: time.com

Droplet lens turns a smartphone into a 160X microscope

See on Scoop.it – sm in healthcare   SOURCE May 1, 2014 Australian scientists have invented a simple and cheap way of making a high-powered lens that can transform a smart phone into See on internetmedicine.com